Market Overview

Insulin Like Growth Factor 1 (IGF-1) Activators Pipeline Insights, 2018 Report - ResearchAndMarkets.com

Share:

The "Insulin
Like Growth Factor 1 (IGF-1) Activators -Pipeline Insight, 2018"

drug pipelines has been added to ResearchAndMarkets.com's
offering.

'Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight,
2018' report offers comprehensive insights of the pipeline (under
development) therapeutics scenario and growth prospects across Insulin
Like Growth Factor 1 (IGF-1) Activators development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Insulin Like
Growth Factor 1 (IGF-1) Activators - Pipeline therapeutics development
coverage provides descriptive product profiles including (but not
limited to) drug description, product development and R&D activities
encompassing clinical and pre-clinical studies, designations,
collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Insulin Like Growth Factor 1 (IGF-1) Activators - Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Insulin Like Growth Factor 1 (IGF-1) Activators Pipeline Products in
Clinical Stages

6. Insulin Like Growth Factor 1 (IGF-1) Activators Pipeline Products in
Non-clinical Stages

7. Therapeutic Assessment: Active Products

8. Inactive Pipeline Products

Companies Mentioned

  • PTC Therapeutics
  • Ceregene
  • Hunter-Fleming
  • Insmed
  • Shire

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/7tpxpn/insulin_like?w=4

View Comments and Join the Discussion!